Effects of tranexamic acid on the activity of glutamate transporter EAAT3

Background Tranexamic acid (TXA) is the most widely used hemostatic agent in surgical patients. However, when used in a high dose, it could cause a seizure in the postoperative period. The exact effector mechanism behind the seizure triggering remains unknown. Therefore, the authors investigated the...

Full description

Bibliographic Details
Main Authors: Hyun-Jung Shin, Soo-Young Lee, Hyo-Seok Na, Bon-Wook Koo, Jung-Hee Ryu, Sang-Hwan Do
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2020-07-01
Series:Anesthesia and Pain Medicine
Subjects:
Online Access:http://www.anesth-pain-med.org/upload/pdf/apm-20004.pdf
_version_ 1797825484215549952
author Hyun-Jung Shin
Soo-Young Lee
Hyo-Seok Na
Bon-Wook Koo
Jung-Hee Ryu
Sang-Hwan Do
author_facet Hyun-Jung Shin
Soo-Young Lee
Hyo-Seok Na
Bon-Wook Koo
Jung-Hee Ryu
Sang-Hwan Do
author_sort Hyun-Jung Shin
collection DOAJ
description Background Tranexamic acid (TXA) is the most widely used hemostatic agent in surgical patients. However, when used in a high dose, it could cause a seizure in the postoperative period. The exact effector mechanism behind the seizure triggering remains unknown. Therefore, the authors investigated the effects of TXA on the activity of glutamate transporter type 3 (excitatory amino acid transporter 3; EAAT3), which is the main neuronal glutamate transporter type. Methods EAAT3 was expressed in Xenopus laevis oocytes through mRNA injection. Oocytes were incubated with diluted tranexamic acid for 72 h. Two-electrode voltage clamping was used to measure membrane currents before, during, and after applying 30 µM L-glutamate. Responses were quantified by integrating the current traces and reported in microcoulombs (µC). Results were presented as mean ± SEM. Results TXA (30 to 1,000 µM) significantly decreased EAAT3 activity. Our kinetic study showed that Vmax was significantly decreased in the TXA group compared with the control group (1.1 ± 0.1 vs. 1.4 ± 0.1 µC, n = 18–23, P = 0.043), but the Km did not significantly change (12.7 ± 3.9 µM for TXA vs. 12.8 ± 3.8 for control, n = 18–23, P = 0.986). Conclusions Our results suggest that TXA attenuates EAAT3 activity, which may explain its proconvulsant effect.
first_indexed 2024-03-13T10:54:39Z
format Article
id doaj.art-beb4c6b7c7ca4fecb538090849d1435d
institution Directory Open Access Journal
issn 1975-5171
2383-7977
language English
last_indexed 2024-03-13T10:54:39Z
publishDate 2020-07-01
publisher Korean Society of Anesthesiologists
record_format Article
series Anesthesia and Pain Medicine
spelling doaj.art-beb4c6b7c7ca4fecb538090849d1435d2023-05-17T05:41:38ZengKorean Society of AnesthesiologistsAnesthesia and Pain Medicine1975-51712383-79772020-07-0115329129610.17085/apm.200041017Effects of tranexamic acid on the activity of glutamate transporter EAAT3Hyun-Jung Shin0Soo-Young Lee1Hyo-Seok Na2Bon-Wook Koo3Jung-Hee Ryu4Sang-Hwan Do5 Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea 2Department of Anesthesiology and Pain Medicine, ThanQ Seoul Thyroid-Head & Neck Surgery Center, Seoul, Korea Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, KoreaBackground Tranexamic acid (TXA) is the most widely used hemostatic agent in surgical patients. However, when used in a high dose, it could cause a seizure in the postoperative period. The exact effector mechanism behind the seizure triggering remains unknown. Therefore, the authors investigated the effects of TXA on the activity of glutamate transporter type 3 (excitatory amino acid transporter 3; EAAT3), which is the main neuronal glutamate transporter type. Methods EAAT3 was expressed in Xenopus laevis oocytes through mRNA injection. Oocytes were incubated with diluted tranexamic acid for 72 h. Two-electrode voltage clamping was used to measure membrane currents before, during, and after applying 30 µM L-glutamate. Responses were quantified by integrating the current traces and reported in microcoulombs (µC). Results were presented as mean ± SEM. Results TXA (30 to 1,000 µM) significantly decreased EAAT3 activity. Our kinetic study showed that Vmax was significantly decreased in the TXA group compared with the control group (1.1 ± 0.1 vs. 1.4 ± 0.1 µC, n = 18–23, P = 0.043), but the Km did not significantly change (12.7 ± 3.9 µM for TXA vs. 12.8 ± 3.8 for control, n = 18–23, P = 0.986). Conclusions Our results suggest that TXA attenuates EAAT3 activity, which may explain its proconvulsant effect.http://www.anesth-pain-med.org/upload/pdf/apm-20004.pdfelectrophysiologyexcitatory amino acid transporter 3glutamate plasma membrane transport proteinstranexamic acidxenopus laevis
spellingShingle Hyun-Jung Shin
Soo-Young Lee
Hyo-Seok Na
Bon-Wook Koo
Jung-Hee Ryu
Sang-Hwan Do
Effects of tranexamic acid on the activity of glutamate transporter EAAT3
Anesthesia and Pain Medicine
electrophysiology
excitatory amino acid transporter 3
glutamate plasma membrane transport proteins
tranexamic acid
xenopus laevis
title Effects of tranexamic acid on the activity of glutamate transporter EAAT3
title_full Effects of tranexamic acid on the activity of glutamate transporter EAAT3
title_fullStr Effects of tranexamic acid on the activity of glutamate transporter EAAT3
title_full_unstemmed Effects of tranexamic acid on the activity of glutamate transporter EAAT3
title_short Effects of tranexamic acid on the activity of glutamate transporter EAAT3
title_sort effects of tranexamic acid on the activity of glutamate transporter eaat3
topic electrophysiology
excitatory amino acid transporter 3
glutamate plasma membrane transport proteins
tranexamic acid
xenopus laevis
url http://www.anesth-pain-med.org/upload/pdf/apm-20004.pdf
work_keys_str_mv AT hyunjungshin effectsoftranexamicacidontheactivityofglutamatetransportereaat3
AT sooyounglee effectsoftranexamicacidontheactivityofglutamatetransportereaat3
AT hyoseokna effectsoftranexamicacidontheactivityofglutamatetransportereaat3
AT bonwookkoo effectsoftranexamicacidontheactivityofglutamatetransportereaat3
AT jungheeryu effectsoftranexamicacidontheactivityofglutamatetransportereaat3
AT sanghwando effectsoftranexamicacidontheactivityofglutamatetransportereaat3